R & D BIOPHARMACEUTICALS GMBH has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ZEDIRA GMBH, BEIJING HANMI PHARMACEUTICAL CO LTD and CURACYTE CHEMISTRY GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | Germany | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Richter Wolfgang | 9 |
#2 | Wolfgang Richter | 2 |
#3 | Doemling Alexander | 2 |
#4 | Henkel Bernd | 2 |
#5 | Beck Barbara | 1 |
#6 | Wessjohann Ludger A Prof Dr | 1 |
#7 | Sakamuri Sukumar | 1 |
#8 | Cappi Michael W | 1 |
#9 | Menon Sanjay | 1 |
#10 | Weber Lutz | 1 |
Publication | Filing date | Title |
---|---|---|
EP2322537A1 | Tubulin inhibitors | |
WO2008138561A1 | Tubulysine derivatives | |
DE102006062278A1 | Preparing an amino acid derivative, comprises reacting carbonyl compound and amine compound, reacting obtained nitrogen containing carbonyl compound with aziridine compound and converting obtained compound to a carbonyl derivative | |
US2005249740A1 | Tubulysin conjugates | |
DE19713970A1 | Epothilone Synthesis Building Blocks II - Prenyl Derivatives |